Remdesivir

• U.S. gives full approval to 1st COVID-19 drug for young children

  The U.S. drug regulator on Monday granted the first full approval for treating COVID-19 in children aged 28 days and older to Gilead Sciences Inc's GILD.O drug remdesivir.

  Health

  Apr 25, 2022
  
• Canadian officials hopeful COVID-19 treatments will help ease strain on hospitals

  A new study suggests the antiviral medication remdesivir could have a “modest but significant effect” on COVID-19 patient outcomes.

  Canada

  Jan 20, 2022
  
• Advertisement
• COVID-19: Remdesivir drops need for ventilation by half, Canadian study says

  The study, published Wednesday in the Canadian Medical Association Journal, is billed as the largest single-country trial of remdesivir reported to date.

  Canada

  Jan 19, 2022
• Advertisement
• Medical supplies from Canada arrive in India as COVID-19 cases, deaths surge

  'Canada stands with our friend and partner India as we work to overcome the devastating impact of #COVID19,' Canada's high commissioner to India tweeted. 

  Canada

  May 8, 2021
• COVID-19 would have been worse without recent advances in science

  The world was 100% more prepared for COVID-19 than it was for the flu 100 years ago, Dr. David Pride says.

  Commentary

  Dec 20, 2020
• Coronavirus therapeutics: A look at COVID-19 treatments in Canada

  From dexamethasone, remdesivir to monoclonal antibodies and convalescent plasma, we look at the various coronavirus therapies being used in Canada.

  Health

  Dec 1, 2020
• WHO’s take on remdesivir leads to more confusion over coronavirus drugs

  Health officials around the world are clashing over the use of certain drugs for COVID-19, leading to different treatment options for patients depending on where they live.

  Health

  Nov 20, 2020
• Remdesivir not recommended for hospitalized coronavirus patients, WHO says

  The advice is another setback for the drug, which grabbed worldwide attention as a potentially effective treatment for COVID-19 in the summer after early trials showed some promise.

  World

  Nov 19, 2020
• Advertisement
• FDA approves first coronavirus drug, may help recovery

  The drug, which California-based Gilead Sciences Inc. is calling Veklury, cut the time to recovery by five days — from 15 days to 10 on average — in a large study led by the U.S. National Institutes of Health.

  World

  Oct 22, 2020
• Advertisement
• Calgary man dies after contracting COVID-19 at Foothills hospital; family seeks remdesivir for daughter on ventilator

  A Calgary family is mourning the death of their father after he was diagnosed with COVID-19 while being treated at the Foothills hospital. The family is fighting for his daughter, who also tested positive, to have access to remdesivir.

  Canada

  Oct 9, 2020